<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Top_Rated_Nine_Fearsome_Fluconazole_Knowledge</id>
		<title>Top Rated Nine Fearsome Fluconazole Knowledge - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Top_Rated_Nine_Fearsome_Fluconazole_Knowledge"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Top_Rated_Nine_Fearsome_Fluconazole_Knowledge&amp;action=history"/>
		<updated>2026-07-05T22:27:04Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Top_Rated_Nine_Fearsome_Fluconazole_Knowledge&amp;diff=161322&amp;oldid=prev</id>
		<title>Shovel9perch: Створена сторінка: 5% of urine isolates were ESBL-producing (Fig.?1). The number of K.?pneumoniae isolates with an ESBL phenotype also increased significantly (p?[http://www.selle...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Top_Rated_Nine_Fearsome_Fluconazole_Knowledge&amp;diff=161322&amp;oldid=prev"/>
				<updated>2017-04-05T10:38:03Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: 5% of urine isolates were ESBL-producing (Fig.?1). The number of K.?pneumoniae isolates with an ESBL phenotype also increased significantly (p?[http://www.selle...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;5% of urine isolates were ESBL-producing (Fig.?1). The number of K.?pneumoniae isolates with an ESBL phenotype also increased significantly (p?[http://www.selleckchem.com/products/Paclitaxel(Taxol).html Selleck Paclitaxel] isolates could not be recultured. Forty-three had originated from urine samples, 36 from pus and wounds, and two from blood cultures. One major PFGE type, AK, consisting of 60 (74%) isolates, was identified (Fig.?2). The isolates of this type were collected from 16 different wards; 59 were healthcare-associated, and only one was community-acquired. The combination of blaSHV-12 and blaTEM was the most prevalent gene combination (75%) in this PFGE type. The majority of the ESBL-producing E.?coli and K.?pneumoniae isolates included in this study were multidrug-resistant (MDR), i.e. resistant to more than three different antimicrobial drug classes. [http://www.selleckchem.com/products/bgj398-nvp-bgj398.html find more] In particular, the prevalence of ciprofloxacin resistance was high (82%). All of the E.?coli isolates of PFGE type?AE and seven (88%) of PFGE type?BE were MDR (Fig.?2). Similarly, 56 (93%) of type?AKK.?pneumoniae isolates were MDR (Fig.?2). Only one carbapenem-resistant K.?pneumoniae isolate was detected. Although the frequency of carbapenem-resistant isolates has increased worldwide, owing to the emergence of KPC carbapenemases and metallo-��-lactamases, carbapenem-resistant K.?pneumoniae strains have remained rare in Finland. In Finland, the number of ESBL-producing E.?coli and K.?pneumoniae isolates had been very low until the end of the 1990s [10], but our results indicate that the situation has changed. We have shown that the number of new infections caused [http://en.wikipedia.org/wiki/Fluconazole Fluconazole] by ESBL-producing E.?coli strains increased dramatically (Fig.?1) within 4?years (2000�C2004) in the Helsinki city area. On the basis of data from 2005 onwards, this trend seems to be continuing (unpublished results). Of course, a similar change in the incidence of ESBL-producing E.?coli to that observed in this study has been observed in several other countries during the same time period [11�C13]. As in other countries, in the Helsinki region, the CTX-M-1-type ��-lactamases are predominant among ESBL-positive E.?coli isolates, regardless of clonal background.&lt;/div&gt;</summary>
		<author><name>Shovel9perch</name></author>	</entry>

	</feed>